Sakar Healthcare Limited (SAKAR.NS)
INR 258.29
(6.94%)
INR 258.29
(6.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 277.32 Million INR | 80.11% |
| 2022 | 153.97 Million INR | 8.56% |
| 2021 | 141.83 Million INR | -9.64% |
| 2020 | 156.97 Million INR | 43.57% |
| 2019 | 109.33 Million INR | 59.46% |
| 2018 | 68.56 Million INR | 74.4% |
| 2017 | 39.31 Million INR | -43.5% |
| 2016 | 69.57 Million INR | 7.92% |
| 2015 | 64.47 Million INR | -4.32% |
| 2014 | 67.38 Million INR | -1.98% |
| 2013 | 68.74 Million INR | 5.64% |
| 2012 | 65.07 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 338.58 Million INR | 0.0% |
| 2023 FY | 280.63 Million INR | 82.26% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 277.32 Million INR | 0.0% |
| 2023 Q2 | 223.33 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 119.61 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 153.97 Million INR | 8.56% |
| 2022 Q4 | 153.97 Million INR | 0.0% |
| 2021 FY | 141.83 Million INR | -9.64% |
| 2021 Q4 | 141.83 Million INR | 0.0% |
| 2021 Q2 | 176.87 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 156.97 Million INR | 43.57% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 156.97 Million INR | 0.0% |
| 2020 Q2 | 141.93 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q4 | 109.33 Million INR | 0.0% |
| 2019 FY | 109.33 Million INR | 59.46% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 102.67 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 51.98 Million INR | 0.0% |
| 2018 Q4 | 68.56 Million INR | 0.0% |
| 2018 FY | 68.56 Million INR | 74.4% |
| 2017 FY | 39.31 Million INR | -43.5% |
| 2017 Q4 | 39.31 Million INR | 0.0% |
| 2017 Q2 | 75.17 Million INR | 0.0% |
| 2016 Q4 | 69.57 Million INR | 0.0% |
| 2016 FY | 69.57 Million INR | 7.92% |
| 2015 Q1 | 68.38 Million INR | 1.49% |
| 2015 Q4 | 64.47 Million INR | 0.0% |
| 2015 Q2 | 68.38 Million INR | 0.0% |
| 2015 FY | 64.47 Million INR | -4.32% |
| 2015 Q3 | 64.47 Million INR | -5.72% |
| 2014 FY | 67.38 Million INR | -1.98% |
| 2014 Q4 | 67.38 Million INR | 0.0% |
| 2013 FY | 68.74 Million INR | 5.64% |
| 2012 FY | 65.07 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 98.313% |
| Hester Biosciences Limited | 755.81 Million INR | 63.308% |
| Aarti Drugs Limited | 4.85 Billion INR | 94.292% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 95.686% |
| Albert David Limited | 436.12 Million INR | 36.411% |
| Alembic Limited | 113.4 Million INR | -144.553% |
| Alkem Laboratories Limited | 26.61 Billion INR | 98.958% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | 6.442% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 80.747% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -987.669% |
| Brooks Laboratories Limited | 96.1 Million INR | -188.554% |
| Eris Lifesciences Limited | 1.89 Billion INR | 85.329% |
| FDC Limited | 3.88 Billion INR | 92.869% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 95.84% |
| Gufic Biosciences Limited | 2 Billion INR | 86.167% |
| Hikal Limited | 3.03 Billion INR | 90.869% |
| Ind-Swift Limited | 640.91 Million INR | 56.73% |
| Innova Captab Limited | 1.44 Billion INR | 80.744% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 93.472% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -84.919% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 97.85% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | 64.062% |
| Lupin Limited | 49.53 Billion INR | 99.44% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 77.57% |
| Medico Remedies Limited | 163.37 Million INR | -69.749% |
| Morepen Laboratories Limited | 2.48 Billion INR | 88.844% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 96.089% |
| Orchid Pharma Limited | 2.64 Billion INR | 89.504% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 74.583% |
| RPG Life Sciences Limited | 1.01 Billion INR | 72.542% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -595.394% |
| Sigachi Industries Limited | 707.2 Million INR | 60.786% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 92.29% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 88.005% |
| Themis Medicare Limited | 705.74 Million INR | 60.705% |
| Unichem Laboratories Limited | 7.04 Billion INR | 96.065% |
| Vaishali Pharma Limited | 3.79 Million INR | -7203.74% |
| Wanbury Limited | 360.23 Million INR | 23.015% |
| Windlas Biotech Limited | 621.89 Million INR | 55.406% |
| ZIM Laboratories Limited | 812.62 Million INR | 65.873% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -165.185% |
| Ipca Laboratories Limited | 24.71 Billion INR | 98.878% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.719% |
| Venus Remedies Limited | 1.21 Billion INR | 77.211% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.717% |
| Divi's Laboratories Limited | 31.84 Billion INR | 99.129% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 87.83% |
| Mankind Pharma Limited | 15.53 Billion INR | 98.215% |
| Sequent Scientific Limited | 3.46 Billion INR | 91.99% |
| Laurus Labs Limited | 18.45 Billion INR | 98.497% |
| Neuland Laboratories Limited | 3.5 Billion INR | 92.086% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 94.481% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 98.896% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 99.194% |
| Amrutanjan Health Care Limited | 289.04 Million INR | 4.056% |
| Wockhardt Limited | 6.4 Billion INR | 95.667% |
| Bal Pharma Limited | 878.11 Million INR | 68.418% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.564% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 76.587% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -563.929% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 92.361% |
| Shilpa Medicare Limited | 3.44 Billion INR | 91.96% |
| Valiant Laboratories Limited | 100.15 Million INR | -176.897% |
| Ajanta Pharma Limited | 8.28 Billion INR | 96.652% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | 20.024% |
| Granules India Limited | 13 Billion INR | 97.868% |
| Medicamen Biotech Limited | 593.75 Million INR | 53.293% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -31.548% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 98.783% |
| NATCO Pharma Limited | 7 Billion INR | 96.041% |
| Suven Life Sciences Limited | 7.08 Million INR | -3814.227% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -183.087% |
| Strides Pharma Science Limited | 11.26 Billion INR | 97.538% |
| Indoco Remedies Limited | 3.53 Billion INR | 92.145% |
| Alpa Laboratories Limited | 136.65 Million INR | -102.94% |
| Lasa Supergenerics Limited | 190.43 Million INR | -45.627% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -1774.817% |